AVEXAEVEX Corp.

🇺🇸 US
11.60
USD
Analysis Scores
Lothien Robustness Score?
44/100
Moderate
Neden bu skor?
Damodaran ?
33/100
ROIC hesaplanamadı: yatırılan sermaye ≤ 0 (özkaynak + net borç) — bu bilançoda ROIC paydası tanımsız
Dalio Risk ?
59/100
Piotroski ?
N/A
Yetersiz çeyrek verisi: 4 mevcut, en az 5 gerekli
Graham ?
Veri Yetersiz
Özkaynaklar negatif veya sıfır — Graham formülü pozitif defter değeri gerektirir
Active Metric?
3/4
Confidence?
59%
Lothien Robustness Summary
68/100
Lothien Sağlamlık: Güçlü (68/100)
Genel tablo olumlu. Finansal yapı sağlam, bazı riskler mevcut. | Kısa Vade: Olumlu | Uzun Vade: Nötr | Pozitif: 8 | Negatif: 4 | Nötr: 1
Net Kâr Pozitif
Son çeyrekte $2M net kâr açıklandı. Şirket kârlı.
Çeyreklik Kâr Düşüşü
Net kâr bir önceki çeyreğe göre %-88.9 geriledi ($21M → $2M). Kısa vadede olumsuz sinyal.
Yıllık Kâr Büyümesi Güçlü
Geçen yılın aynı dönemine göre net kâr %+119.7 arttı. Büyüme trendi sağlıklı.
Yıllık Hasılat Büyümesi Güçlü
Yıllık hasılat %+99.5 arttı. Şirket büyüyor.
Çok Düşük Net Kâr Marjı
Net kâr marjı sadece %1.2. Küçük bir maliyet artışı şirketi zarara sokabilir.
Net Nakit Pozisyonu
Şirketin nakdi borçlarından $107M fazla. Borç riski düşük.
Güçlü Likidite
Cari oran 5.66x — kısa vadeli borçları rahat karşılıyor.
Borç Azalıyor
Toplam borç çeyreklik %-59.3 düştü. Bilanço güçleniyor.
Güçlü Nakit Üretimi
Serbest nakit akışı ($17M) kârın %728'sini nakit olarak üretiyor. Kâr kalitesi yüksek.
FAVÖK Düşüşü
FAVÖK çeyreklik %-43.4 düştü. Operasyonel performans zayıflıyor.
Makul F/K
Trailing F/K: 14.2. Makul değerleme aralığında.
Özkaynak Eriyor
Özkaynak çeyreklik %-271.3 düştü. Zarar veya temettü ile sermaye eriyor.
Sonraki Çeyrek: Artış Beklentisi
Pusla tahminine göre bir sonraki çeyrekte kâr %+145.5 artabilir ($2M → $6M).

Data date 2026-11-10 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date 2026-11-10
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Risk Analysis (VaR) Çok Yüksek
144 days
Annual Volatility ?
%124.7
VaR 95% ?
%13.19
daily max loss
VaR 99% ?
%18.54
daily max loss
CVaR 95% ?
%16.24
expected loss (tail)
Max Drawdown ?
%77.1
28.05.2026 → 05.11.2026
Skewness ?
0.20
Parametrik%13.19
Historik%11.12
Cornish-Fisher%12.27
Return Distribution
Valuation
Potential?
-14.0%
DCF Value ?
5.39
Debt Cycle?
Early Expansion
Balance Sheet Analysis? Q2026/9
Son 2 çeyrek ardışık kâr
Fiyat TRAMA-99 altında: %-32.1 — teknik trend olumsuz
Direnç seviyesi: TRAMA-99 = 17.09 USD
Fundamental & Technical Analysis
Profitability
Net Profit Margin %1.2
Net profit margin %1.2 — positive but low. Compared to previous quarter -8.5 point decrease.
ROE - Return on Equity (TTM) %-20.9
ROE %-20.9 — negative return on equity.
EBITDA Margin %9.2
EBITDA margin %9.2 — moderate operational efficiency.
Gross Profit Margin %23.6
Gross profit per revenue %23.6. Evaluate relative to sector.
Free Cash Flow Margin (TTM) %-4.7
TTM Free Cash Flow is %-4.7'i. Negative FCF — company consuming cash.
Valuation
P/E Ratio 14.2x Sector: 26.3x
F/K 14.2x — sector median's (26.3x) %46 below. Attractive for value investing.
EV/EBITDA 14.3x Sector: 15.6x
EV/EBITDA 14.3x — sector median (15.6x) in line.
Indebtedness
Current Ratio 5.66x
Current ratio 5.66x — current assets are 2x short-term liabilities. Very healthy liquidity.
Net Debt / EBITDA 2.8x
Net Debt/EBITDA 2.8x — manageable debt level.
Interest Coverage 1.5x
Interest coverage 1.5x — limited buffer. May tighten if profitability drops.
Growth
Revenue Growth (YoY) %+99.5
Revenue YoY %99.5 grew (2026/6) — strong growth. Sector expansion and/or market share increase.
Net Profit Growth (YoY) %+119.7
Net profit turned from loss to profit (2026/6). Significant improvement.
Score Explanations
Lothien Robustness
44/100
Moderate robustness (44/100). Valuation and risk criteria give mixed signals. Detailed review recommended.
Moderate
Potential
-14.0%
Minus %14.0 expected value (10.03) vs current price comparison. 3/4 valuation models could be calculated. Model confidence %59.
Components: PE target: 7.98 | EV/EBITDA target: 12.76 | DCF target: 5.39
Damodaran Valuation
33/100
Weak
Dalio Risk Analysis
59/100
Moderate debt risk (59/100). Interest coverage ratio 1.5x — weak, fragile. Debt/EBITDA 2.8x — manageable.
Leverage: 65/100 | Debt Service: 69/100 | Quality: 31/100
DCF Discounted Cash Flow
5.39
DCF (5.39) current price %53.8 below — cash flows do not support current price.
Current price: 11.67
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
—
Graham Intrinsic Value
—
⚖️ Sector Comparison
P/E Ratio
14.2x vs 26.3x
Sector median's %46 below — cheap
EV/EBITDA
14.3x vs 15.6x
Compared to sector %9 lower EV/EBITDA
Net Profit Margin (TTM)
%-2.8 vs %6.7 EBITDA margin
TTM net profit margin %-2.8
TRAMA-99 Trend — Strong Downtrend
Price (11.60), TRAMA-99 line's %32.1 below. Significant downtrend. TRAMA line acts as strong technical resistance.
Price:: 11.60
TRAMA: 17.09
Difference: %-32.1
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
▲ içeriden alım · ▼ içeriden satım · ★ katalizör (haber-sezgisel) · ■ 13D aktivist · ■ 13G pasif — SEC Form 4 ~2 gün gecikmeli, yalnız yönetici/direktör/%10+ sahip; katalizör = haber-sezgisel; 13D/G = %5+ pay bildirimi ~5 iş günü gecikmeli.
RSI (14) ?
Bollinger Bands ?
MACD ?
Gold-Based Price + TRAMA (Stock / Gram Gold) ?
Kurumsal Holdings — 13F (çeyreklik) ?

İçeriden Alım-Satım Akışı

Kim aldı, kim sattı, ne kadar

AVEX — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.